The association among glutamate, GABA, and anterior cingulate connectivity in schizophrenia spectrum disorders: Implications for symptom domainsShow others and affiliations
2026 (English)In: European psychiatry, ISSN 0924-9338, E-ISSN 1778-3585, Vol. 69, no 1, p. 1-10, article id e54Article in journal (Refereed) Published
Abstract [en]
Background. Schizophrenia-spectrum disorders (SSD) are characterized by structural and functional brain abnormalities, including disrupted functional connectivity within networks such as the salience network. The anterior cingulate cortex (ACC), a core hub of this network, has shown alterations in the major neurotransmitter systems comprising glutamate (Glu) and gamma-aminobutyric acid (GABA). While dysfunctional glutamatergic signaling has been proposed as a key mechanism in SSDs, the relationship between anterior cingulate cortex (ACC) functional connectivity, glutamatergic neurotransmission, and clinical symptomatology remains poorly understood.
Methods. Here, we combined resting-state functional MRI to measure functional brain connectivity with proton magnetic resonance spectroscopy to measure Glu and GABA levels in the dorsal ACC of 26 patients with schizophrenia spectrum disorders and 38 healthy controls.
Results. Patients showed reduced connectivity within the salience network compared to controls. Across the whole sample, a dorsal ACC-seed showed glutamate-dependent connectivity to several clusters, including right insula, thalamus, and cerebellum. In patients, the averaged connectivity of these clusters was associated with positive symptom severity.
Conclusions. These findings suggest that disrupted glutamatergic modulation of large-scale brain networks may underlie core clinical features in schizophrenia spectrum disorders.
Place, publisher, year, edition, pages
Cambridge University Press, 2026. Vol. 69, no 1, p. 1-10, article id e54
Keywords [en]
GABA, glutamate, MRS, rs-fMRI, schizophrenia spectrum disorders
National Category
Psychiatry Neurosciences Radiology and Medical Imaging Neurology
Identifiers
URN: urn:nbn:se:uu:diva-587498DOI: 10.1192/j.eurpsy.2026.12212ISI: 001771842700001PubMedID: 42057649Scopus ID: 2-s2.0-105038245491OAI: oai:DiVA.org:uu-587498DiVA, id: diva2:2068249
2026-06-092026-06-092026-06-09Bibliographically approved